Evaluation of Feasibility to Categorize Borderline Resectable Pancreatic Ductal Adenocarcinoma as T4 Tumor. (2022) - Miyata, Y.; Takihata, Y.; Nakazawa, A.; Iwasaki, T.; Einama, T.; Beck, Y.; Kishi, Y.